Current stock page

Financial Data

LIVN Financial Data

Revenue · Earnings · Margins · Balance Sheet · Cash Flow

HealthcareMedical - DevicesScore data as of Nov 18, 2026

LIVNLivaNova PLC

Healthcare / Medical - Devices

Leader

Strong Relative Position

BullishEdge 9/10
$94.54+$2.62 (+2.85%)

Latest quote

  • Momentum
    83
  • Value
    60
  • Quality
    64
  • Risk resilience
    71
  • Sentiment
    —
algovestiq.comScore data as of Nov 18, 2026

Latest Quarter at a Glance

Quarter ended Sep 30, 2026, compared with the same quarter a year earlier.

Revenue
$393.1M
+9.9% YoY
Net income
$34.3M
+28.0% YoY
Free cash flow
$42.8M
−31.2% YoY
Operating margin
7.2%
−7.9 pts YoY

Quarterly Financial Statements

Updated Nov 19, 2026.

LIVN, last 8 quarters. YoY compares the latest quarter with the same quarter a year earlier.

Income statement
Income statement, last 8 quarters, newest first
MetricTrendYoYSep '26Jun '26Mar '26Dec '25Sep '25Jun '25Mar '25Dec '24
Revenue+9.9%$393M$391M$362M$361M$358M$353M$317M$322M
Gross profit+8.2%$265M$274M$245M$240M$245M$239M$221M$219M
Operating income−47.4%$28M$50M$52M$43M$54M$54M$49M$37M
Net income+28.0%$34M$109M$22M$31M$27M$27M−$327M$56M
EPS (diluted)+22.4%$0.60$1.93$0.40$0.57$0.49$0.50−$6.01$1.02
Gross margin−1.0 pts67.4%70.1%67.6%66.4%68.4%67.8%69.7%68.2%
Operating margin−7.9 pts7.2%12.7%14.4%11.8%15.1%15.4%15.3%11.5%
Net margin+1.2 pts8.7%27.8%6.2%8.6%7.5%7.7%-103.3%17.4%
Cash flow
Cash flow, last 8 quarters, newest first
MetricTrendYoYSep '26Jun '26Mar '26Dec '25Sep '25Jun '25Mar '25Dec '24
Operating cash flow−13.5%$74M$67M$15M$82M$85M$63M$24M$79M
Capital expenditure−34.6%−$31M−$32M−$14M−$32M−$23M−$15M−$11M−$10M
Free cash flow−31.2%$43M$35M$926K$50M$62M$48M$13M$68M
Free cash flow margin−6.5 pts10.9%9.0%0.3%13.9%17.4%13.6%4.2%21.2%
Balance sheet
Balance sheet, last 8 quarters, newest first
MetricTrendYoYSep '26Jun '26Mar '26Dec '25Sep '25Jun '25Mar '25Dec '24
Total assets+6.1%$2.71B$2.64B$2.52B$2.61B$2.56B$2.51B$2.56B$2.51B
Total liabilities−4.2%$1.34B$1.32B$1.30B$1.41B$1.40B$1.38B$1.52B$1.19B
Shareholders' equity+18.6%$1.37B$1.33B$1.21B$1.20B$1.16B$1.12B$1.03B$1.32B
Total debt−28.5%$348M$352M$335M$473M$487M$483M$678M$677M
Cash and equivalents−12.8%$564M$517M$540M$636M$646M$594M$738M$429M
Valuation and ratios
Valuation and ratios, last 8 quarters, newest first
MetricTrendYoYSep '26Jun '26Mar '26Dec '25Sep '25Jun '25Mar '25Dec '24
P/E ratio26.6823.3334.57————36.07
P/B ratio+1.393.813.323.063.192.422.312.291.73
Return on equity+33.1 pts14.3%14.2%8.8%-20.2%-18.8%-18.8%-21.5%4.8%
Debt to equity−0.170.250.270.280.390.420.430.660.51
Free cash flow yield−4.4 pts2.5%3.4%4.3%4.5%6.8%6.3%6.1%6.0%

Current Stock Metrics

Current fundamental, technical, and risk readings in one place.

Fundamental metrics
MetricValue
P/E ratio25.68x
P/B ratio3.69x
Revenue growth (YoY)9.87%
EPS growth (YoY)26.53%
Gross margin67.91%
Operating margin11.46%
ROE15.35%
ROIC8.74%
Debt to equity0.25
FCF yield2.55%

As of Nov 18, 2026

Technical indicators
MetricValue
Close
As of Nov 18, 2026
$94.54
Volume
As of Nov 13, 2026
742,278
RSI (14)
As of Nov 13, 2026
65.47
MACD
As of Nov 13, 2026
3.55
MACD signal
As of Nov 13, 2026
2.82
MACD histogram
As of Nov 13, 2026
0.72
ADX (14)
As of Nov 13, 2026
30.8
SMA (50)
As of Nov 13, 2026
$80.32
SMA (200)
As of Nov 13, 2026
$74.18
ATR (14)
As of Nov 13, 2026
$3.32
Historical volatility (annualized)
As of Nov 13, 2026
69.17%
Volume (20-day average)
As of Nov 13, 2026
762,455
Risk measures
MetricValue
Resilience score71/100
Beta1.09
Annual volatility39.16%
Max drawdown-18.89%
Sharpe ratio1.38
VaR (95%, 1-day)-2.93%

As of Nov 18, 2026

Detailed Metrics

Additional measures remain available here while the decision pages stay focused.

Additional fundamental metrics

No additional fundamental metrics are available.

Additional technical indicators

No additional technical indicators are available.

Additional risk measures

No additional risk measures are available.

LIVN Financial Data FAQ

What is LivaNova PLC's revenue?

LivaNova PLC's revenue is one of the core financial data points for LIVN. Use it with revenue growth, margins, and EPS to understand whether sales are translating into earnings power.

Is LivaNova PLC's revenue growing?

Revenue growth shows whether LivaNova PLC is expanding from prior periods. Compare growth with margins and free cash flow because faster sales growth is more valuable when profitability holds up.

What is LIVN's EPS?

LIVN's EPS, or earnings per share, helps connect net income to each share. EPS should be compared with EPS growth, P/E ratio, and analyst expectations.

What is LivaNova PLC's net income?

LivaNova PLC's net income shows profit after costs, taxes, and other expenses. It should be read with revenue, operating margin, EPS, and free cash flow.

How much free cash flow does LivaNova PLC generate?

Free cash flow shows how much cash LivaNova PLC generates after capital spending. It is useful for judging reinvestment capacity, buybacks, debt reduction, and valuation support.

How much cash and debt does LivaNova PLC have?

Cash and debt help frame LIVN's balance-sheet flexibility. Compare liquidity and leverage with free cash flow and profitability before judging financial strength.